The -1082A>G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysis

被引:0
作者
Chunxue Li
Weidong Tong
Baohua Liu
Anping Zhang
Fan Li
机构
[1] Institute of Surgery Research,Department of General Surgery
[2] Daping Hospital,undefined
[3] Third Military Medical University,undefined
来源
Scientific Reports | / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The -1082A>G polymorphism is located in promoter region of interleukin-10 (IL-10) and it could affect the production of IL-10. Numerous studies have investigated the association between IL-10 -1082A>G and risk of digestive cancer. However, the conclusion is still inconsistent. Here, we have performed a meta-analysis and systematic review to determine the association between the IL-10 -1082A>G and susceptibility to digestive cancer. In this meta-analysis, we identified 40 eligible studies, involving 7195 patients of digestive cancer and 11755 controls. By pooling all eligible studies, we found the variant -1082G allele significantly increased risk of digestive cancer (G vs. A: OR = 1.181, 95% CI: 1.057–1.319). Further stratified analysis was performed to evaluate the influence of cancer types, ethnicities, study design, sample size and Hardy–Weinberg equilibrium. Stratified analysis suggested that, the -1082A>G polymorphism was only associated with increased risk for gastric cancer (G vs. A: OR = 1.281, 95% CI: 1.102–1.488) and in Asian population (G vs. A: OR = 1.399, 95% CI: 1.188–1.646). No significant publication bias was detected. Based on 40 studies and 18950 participants, we found the variant IL-10 -1082G allele significantly increased susceptibility to digestive cancer, especially for gastric cancer and in Asian population.
引用
收藏
相关论文
共 126 条
[1]  
Lee AS(2013)A current review of molecular mechanisms regarding osteoarthritis and pain Gene 527 440-447
[2]  
Kapoor M(2011)Role of proinflammatory cytokines in the pathophysiology of osteoarthritis Nat Rev Rheumatol 7 33-42
[3]  
Martel-Pelletier J(1989)Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 2081-2095
[4]  
Lajeunesse D(2008)Interleukin-10: new perspectives on an old cytokine Immunol Rev 226 205-218
[5]  
Pelletier JP(2001)Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683-765
[6]  
Fahmi H(2005)Interleukin-10 and the immune response against cancer: a counterpoint J Leukoc Biol 78 1043-1051
[7]  
Fiorentino DF(2013)Role of IL-10 in the progression of kidney disease World J Transplant 3 91-98
[8]  
Bond MW(2009)Biology of TNFalpha and IL-10 and their imbalance in heart failure Heart Fail Rev 14 113-123
[9]  
Mosmann TR(2008)Strategies for use of IL-10 or its antagonists in human disease Immunol Rev 223 114-131
[10]  
Mosser DM(2003)Interleukin-10 therapy--review of a new approach Pharmacol Rev 55 241-269